• KI
  • SU
  • KTH

Diseases of the brain and central nervous system have the largest impact on society than any other single disease area. In the European alone, the estimated impact on society of these diseases is estimated to be well over 800 billion €. And now, following numerous failures in clinical trials, many large pharmaceutical companies have decided to largely abandon research and development in CNS diseases, including all companies in Sweden, leaving a large unmet and unaddressed need.



Vision: The Berzelii Centre Stockholm Brain Institute (“Centre”) will work collaboratively to identify and exploit innovations from our translational neuroscience research to specifically address the enormous unmet need in brain disorders and to markedly improve patient’s lives and the burden on society.

Mission: To be an internationally recognised centre in translational neuroscience that attracts, develops and commercialises partnerships with the private and public sectors. In these partnerships we will develop joint projects that exploit our expertise to lead to novel ways to diagnose, treat, or prevent brain disorders.


The objectives are:

  • Innovative research in collaboration with the public and private sectors that meets specific needs of society
  • International leadership in translational neuroscience
  • Sustainability